Vyriad secures final $25M Series B tranche, totaling $85M, to advance its in vivo CAR T candidate into clinic, led by Harry Stine.
Amount Raised
$25 Million
Round Type
Series B
Investors
Description
Vyriad, Inc. has announced the closing of a $25M final tranche to its Series B financing, increasing the total to $85M. This funding supports the imminent first-in-human testing of its in vivo CAR T candidate, VV169. The round was led by Harry Stine of Stine Seed Farms, with participation from several significant family offices
Quick answer
Vyriad raised $25 Million in a Series B round, dated December 23, 2025. Investors: Stine Seed Farms, Stine Seed Farms, Inc. and Harry Stine. Vyriad is based in Rochester, New York, United States.
- How much did Vyriad raise?
- Vyriad raised $25 Million in a Series B round on December 23, 2025.
- Who invested in Vyriad?
- Stine Seed Farms, Stine Seed Farms, Inc. and Harry Stine are named as investors in this round.
- What does Vyriad do?
- Vyriad is a clinical-stage biotechnology company developing targeted genetic medicines for cancer and other serious diseases.
- Where is Vyriad based and how big is it?
- Vyriad is based in Rochester, New York, United States. Fundz records about 52 employees.
- Who are the decision-makers at Vyriad?
- Fundz holds 2 contacts at Vyriad, including the EVP. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Vyriad that raised within 45 days of this round, from Fundz verified event records.
- Enveric Biosciences raised $1.5M on January 28, 2026.
- PrognomiQ raised $12M on January 2, 2026.
- MAIA Biotechnology raised $1.5M on December 22, 2025.
- Atavistik Bio raised $120M (Series B) on December 21, 2025.
- Enveric Biosciences raised $107K on December 12, 2025.
- Aprea Therapeutics raised $3.1M on December 10, 2025.
Who to call at Vyriad, and when
A new round usually means Vyriad is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vyriad raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vyriad, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vyriad. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vyriad raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansVyriad raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.